AGN-192403

N/A

Report date: 2023/02/04 20:01:16
NME

Base Information

Drug NameAGN-192403
Drug Alias NameAGN-192403
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImidazoline I1 receptors agonists
TargetsImidazoline I1 receptors
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAllergan Pharmaceuticals International Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbvie Inc
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A